Dr. Inga Hofmann

Natalie Callander, MD, is a UW Health hematologist specializing in blood disorders and multiple myeloma blood cancer. She’s also a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health.Dr. Callander treats multiple myeloma and complications such as anemia, bone fractures and infections. She leads the multiple myeloma clinical program at the UW Health|Carbone Cancer Center. Dr. Callander’s specialties include advanced stem cell transplantation, during which patients may receive their own transplanted cells or compatible donor cells.Understanding that cancer care can feel overwhelming, Dr. Callander takes time to listen to her patients and guide them through treatment options and care. She reassures patients and shares resources and medical advances that can greatly improve their treatment results and quality of life.Dr. Callander and her UW Health colleagues are at the forefront of research for multiple myeloma. Her research focuses on autologous (self) stem cell transplantation and new cellular and medical therapies for multiple myeloma. She invites her patients to participate in clinical studies that can benefit them personally while also contributing to improved cancer care.Outside of work, Dr. Callander enjoys cooking and spending time with her family.It’s been incredibly gratifying to take care of patients that I met 20 years ago who are doing great. Dr. Callander is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Callander is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Callander is currently accepting new patients.

Vaishalee Kenkre, MD, is a UW Health hematologist and an associate professor in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health.Dr. Kenkre treats patients with all types of lymphoma, a blood cancer, including Hodgkin lymphoma and non-Hodgkin lymphoma. As part of the cellular therapy group team, she provides care for people who need a bone marrow transplant or CAR T-cell therapy.Dr. Kenkre finds the field of hematology to be a fulfilling specialty because she can help people through their treatment. Though the care she provides is very clinical, she believes compassion is key. She enjoys getting to know each of her patients in order to tailor their care to best meet their needs and preferences.In addition to her clinical and teaching roles, Dr. Kenkre is involved with clinical research trials for people with lymphoma.In her free time, Dr. Kenkre enjoys traveling and spending time with her children.Even though the medical part of what I do is very clinical, getting to know each person’s experiences and expectations allows me to tailor their care to fit their unique needs. Dr. Kenkre is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kenkre is board certified in Hematology and Medical Oncology. Dr. Kenkre is currently accepting new patients.

Dustin Deming, MD, is a UW Health medical oncologist with a clinical emphasis on gastrointestinal cancers, including colon, rectal, anal, esophageal, liver and pancreatic cancers. He is also a professor at the University of Wisconsin School of Medicine and Public Health in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care. Dr. Deming is known for his commitment to delivering evidence‑based, compassionate care to patients facing complex cancer diagnoses.Dr. Deming’s research program focuses on developing improved treatments for specific subtypes of colon cancer and other gastrointestinal malignancies. His work centers on understanding how tumor‑specific genetic mutations influence treatment response, with the goal of creating personalized therapy regimens for individual patients. By using advanced animal models, his research helps bridge the gap between laboratory discoveries and clinical application.In addition to his translational research, Dr. Deming’s laboratory has developed innovative three‑dimensional cell culture techniques to advance clinical cancer research. He also leads efforts to identify new and improved biomarkers to better predict disease behavior and treatment outcomes. Through his combined roles as a clinician, researcher, and educator, Dr. Deming contributes to advancing precision oncology and improving care for patients with gastrointestinal cancers. Dr. Deming is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, Familial Colorectal Cancer, Anal Cancer, and Liver Embolization. Dr. Deming is board certified in Internal Medicine and Medical Oncology. Dr. Deming is currently accepting new patients.

Dr. Lang is a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Madison, WI. He specializes in genitourinary cancer and medical oncology. Dr. Lang is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Nasopharyngeal Carcinoma, Renal Cell Carcinoma (RCC), Prostatectomy, and Nephrectomy. Dr. Lang is board certified in Internal Medicine and Medical Oncology. Dr. Lang is currently accepting new patients.

Julie Chang is a Hematologist and an Oncologist practicing medicine in Madison, Wisconsin. Dr. Chang is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Richter Syndrome, and Bone Marrow Aspiration. Dr. Chang is board certified in American Board Of IM/Hematology , Wisconsin Medical Examining Board, and Drug Enforcement Administration . Dr. Chang is currently accepting new patients.

Glenn Liu, MD, is a UW Health medical oncologist and a professor in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health.Dr. Liu specializes in treating advanced genitourinary cancers. These include cancers affecting the urinary and male reproductive organs such as the prostate, bladder, kidneys and testicles. Dr. Liu cares for patients who are both newly diagnosed and those with recurrent (returning) cancer.Dr. Liu’s care philosophy is based on shared decision-making. He believes that listening to patients is essential. He listens to their concerns and educates them about their condition and treatment options. He is excited about the many new discoveries happening now in the field of medical oncology and offers personalized care to best meet his patients’ needs.In addition to his clinical and teaching roles, Dr. Liu researches new cancer therapies. This includes testing new treatments, improving decision-making processes and enhancing how health care teams interact with patients.Outside of work, Dr. Liu enjoys playing tennis, hiking and fishing.Being able to answer questions and provide support and help is very rewarding. Dr. Liu is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Orchiectomy. Dr. Liu is board certified in Medical Oncology. Dr. Liu is currently accepting new patients.